After a Texas federal judge ordered the Food and Drug Administration (FDA) to accelerate the release of the data it relied on to license the Pfizer/BioNTech COVID-19 two-dose injection, the latest documents reveal that the drug company hired about 600 additional full-time employees with plans to hire 1,800 more by June 2021 to process the “large number of adverse events” they saw as early as February 28, 2021.
The rollout of the Pfizer injection led to an unprecedented number of reported adverse events, yet neither the drug company nor the FDA disclosed this critical information to the public.
This information was contained in a more than 11,000-page document cache released April 1, 2022 by the FDA as part of a court-ordered disclosure schedule stemming from an expedited Freedom of Information Act (FOIA) request. The document, “Cumulative Analysis of Post-Authorization Adverse Event Reports” of the Pfizer-BioNTech injection, highlights adverse events identified through Feb. 28, 2021. The document was previously released in November 2021, but the number of employees Pfizer hired and planned to hire was redacted.
According to the unredacted document released April 1, “Pfizer has also taken a multiple actions [sic] to help alleviate the large increase of adverse event reports. This includes significant technology enhancements, and process and workflow solutions, as well as increasing the number of data entry and case processing colleagues. To date, Pfizer has onboarded approximately 600 additional full-time employees (FTEs). More are joining each month with an expected total of more than 1,800 additional resources by the end of June 2021.”
The unredacted version also revealed that “approximately 126,212,580 doses of BNT162b2 [the Pfizer EUA vaccine] were shipped worldwide from the receipt of the first temporary authorisation [sic] for emergency supply on 01 December 2020 through 28 February 2021.”
Last January, U.S. District Judge Mark Pittman ordered the FDA to produce more than 12,000 pages on or before Jan. 31 and to “produce the remaining documents at a rate of 55,000 pages every 30 days, with the first production being due on or before March 1, 2022, until production is complete.”
In the first 55,000-page set of documents previously released, the FDA’s Center for Biologics Evaluation and Research allowed the public to access data for the first time that Pfizer submitted to the FDA from its clinical trials in support of a COVID-19 “vaccine” license. Hidden in one appendix is a 38-page report of clinical data for Pfizer’s “vaccine” which lists 1,291 adverse side effects of the shot in alphabetical order.
The list includes acute kidney injury, acute flaccid myelitis, anti-sperm antibody positive, brain stem embolism, brain stem thrombosis, cardiac arrest, cardiac failure, cardiac ventricular thrombosis, cardiogenic shock, central nervous system vasculitis, death neonatal, deep vein thrombosis, encephalitis brain stem, encephalitis hemorrhagic, frontal lobe epilepsy, foaming at mouth, epileptic psychosis, facial paralysis, fetal distress syndrome, gastrointestinal amyloidosis, generalized tonic-clonic seizure, Hashimoto’s encephalopathy, hepatic vascular thrombosis, herpes zoster reactivation, immune-mediated hepatitis, interstitial lung disease, jugular vein embolism, juvenile myoclonic epilepsy, liver injury, low birth weight, multisystem inflammatory syndrome in children, myocarditis, neonatal seizure, pancreatitis, pneumonia, stillbirth, tachycardia, temporal lobe epilepsy, testicular autoimmunity, thrombotic cerebral infarction, Type 1 diabetes mellitus, venous thrombosis neonatal, and vertebral artery thrombosis among 1,246 other medical conditions following vaccination.
As part of Judge Pittman’s order, the FDA disclosure schedule includes:
- 80,000 pages apiece, to be produced on or before May 2, June 1 and July 1, 2022.
- 70,000 pages to be produced on or before Aug. 1, 2022.
- 55,000 pages per month, on or before the first business day of each month thereafter, until the release of the documents has been completed.
Congress appropriated $1 billion in fiscal year 2021 for the secretary of health to spend on activities to “strengthen vaccine confidence in the United States.” Then hundreds of news organizations were paid by the federal government to advertise for the shots as part of a comprehensive media campaign by the U.S. Department of Health and Human Services (HHS). The “COVID-19 Public Education Campaign,” a “national initiative to increase public confidence in and uptake of COVID-19 vaccines,” was created with the goal of having “trusted messengers and influencers” speak to news organizations to “provide factual, timely information and steps people can take to protect themselves, their families, and their communities.”
This information was revealed in response to a FOIA request filed by Blaze Media. This request uncovered that the HHS purchased advertising on TV, radio, in print, and on social media to build “vaccine confidence.” Media networks including ABC, CBS, NBC, Fox News, CNN, Newsmax, MSNBC, New York Post, Los Angeles Times, Washington Post, BuzzFeed News and hundreds of local newspapers and TV stations were collectively responsible for publishing countless articles and video segments promoting the COVID shots as effective and safe.
Liberty Counsel Founder and Chairman Mat Staver said, “People have been injured and died as a result of the most extensive cover-up campaign in U.S. history. These COVID shots are neither safe nor effective and the truth has been censored and the public has been fed lies by the U.S. government, the drug companies, and the media. This is a crime against humanity.”
